Endo Launches Generic Version Of Pfizer's Smoking Cessation Pill

Endo International plc's ENDP operating company, Par Pharmaceutical Inc, has begun shipping the generic version of Pfizer Inc's PFE Chantix (varenicline), 0.5 mg and 1 mg tablets.
Chantix is a prescription medicine to help adults stop smoking.
Related Content: Pfizer Pulls Out Additional Lots Of It Anti-Smoking Pill.
Par's varenicline is currently the only available FDA-approved generic version of Chantix in the U.S.
According to IQVIA, Chantix tablet sales were approximately $1 billion for the 12 months ended June 30, 2021.
Price Action: ENDP stock is up 8.33% at $2.99 during the market session on the last check Wednesday.

Momentum23.64

Growth97.00

Quality53.60

Value32.29

Short

Medium

Long